01/20/2010 | Bio-IT World | John Russell
Turning FDA's Critical Path Initiative (CPI) into practical tools to accelerate drug discovery and development has had its challenges. But that hasn't deterred Ray Woosley, CEO of the C-PATH Institute, whose sole mission is to foster private-public cooperation to fulfill CPI's grand vision. Woosley is a glass-half-full realist and C-PATH is starting to justify his steady confidence.
Sanofi-aventis raises a glass
01/20/2010 | The Explorer | Dave Perry
Flutes of champagne were lifted skyward last Wednesday morning in Oro Valley, where Sanofi-aventis associates from across the nation and beyond celebrated the opening of the company's 110,350-square-foot Tucson Research Center.
T-Gen-Van Andel deal spurs new contract
01/17/2010 | Arizona Republic | Ken Alltucker
After months of review, the Arizona Biomedical Research Commission last week signed off on a new contract that ensures continued funding of Phoenix-based Translational Genomics Research Institute. The commission sought the new contract with TGen to protect Arizona's interests in the wake of TGen's alliance with Grand Rapids, Mich.-based Van Andel Institute.
Sanofi-Aventis unveils state-of-art research facility
01/15/2010 | Inside Tucson Business | Joe Pangburn
Sanofi-Aventis, one of the world's largest pharmaceutical companies, has a cure for needed research space: Last week, it showed off its expanded Tucson Research Center, a 110,350 square-foot, state-of-the-art facility in Oro Valley's Innovation Park.
Infrastructure projects help stimulate economy, pave way for growth
01/15/2010 | Phoenix Business Journal
According to Arizona's Bioscience Roadmap, commissioned and coordinated by the Flinn Foundation, the state needs to focus on four strategies to develop a strong bioscience hub. Here are those strategies and how the greater Phoenix area has fared since the October report.
ASU, Mayo partner to fight diseases related to obesity
01/15/2010 | Phoenix Business Journal | Angela Gonzales
Arizona State University and Mayo Clinic in Scottsdale are partnering to combat diseases associated with obesity, Type II diabetes, cardiovascular disease, stroke and other expensive conditions. The two organizations have created the ASU/Mayo Center for Metabolic and Vascular Biology, which is recruiting 50 doctors and scientists.
Several Valley biotech firms are marketing health-related products
01/15/2010 | Phoenix Business Journal | Angela Gonzales
The theme for biotech startups in Arizona this year is shaping up to be "health and fitness." Local entrepreneurs are working on everything from vibrating fitness gear to breath analyzer technology used to determine how effectively a person burns fat during a workout.
5 Questions about Arizona Bioscience: Robert Green, AZBio President and CEO
01/15/2010 | Phoenix Business Journal
How has the state's bioscience community fared during the recession? Looking into your crystal ball, what is the outlook for access to financing in 2010 for biotech startups and spinouts? Has AZBio made any adjustments based on the current economic situation? Coming from Tucson, how will you help Phoenix and Tucson bioscience entities collaborate this year? What is AZBio's focus this year?
UA researchers part of $44B biofuel program
01/13/2010 | Phoenix Business Journal | Angela Gonzales
Several University of Arizona researchers are part of a consortium that received a $44 million U.S. Department of Energy grant to bring algae-based biofuels to market. The federal agency announced on Wednesday that nearly $80 million under the American Recovery and Reinvestment Act will be awarded to the National Advanced Biofuels Consortium and the National Alliance for Advanced Biofuels and Bioproducts. UA is a founding member of the latter.
AZ Economic Driver Biosciences Could Stall After 2010
01/13/2010 | Tech News Arizona | Alan Fischer
Arizona's bioscience sector continued to grow despite a hard-hitting global recession and cutbacks in supporting state funding, according to an industry update released this week throughout the state and on Jan. 12 at the Flinn Foundation in Phoenix.
AZ biosciences buck recession as jobs increase
01/13/2010 | Arizona Daily Star | David Wincher
Arizona's biosciences sector made notable gains in 2008 and 2009 despite the recession and its lingering effects, according to a report issued Tuesday. But the state saw its federal medical research grants fall 10 percent, and venture capital remained scarce, says an annual update on the state's 10-year biosciences development plan.
Bioscience industry grows despite budget woes
01/13/2010 | Arizona Republic | Ken Alltucker
Arizona's push to grow the bioscience industry has paid off over the past two years with rapid job growth and new companies despite the difficult economy, a new report says. Although Arizona has made progress on most goals outlined in the annual report by Ohio-based Battelle Technology Partnership Practice, the state's budget woes and lack of early-stage investment in startup companies are challenges that could slow bioscience growth and the high-wage jobs the industry delivers.
Biosciences growth could slow amid budget cuts
01/12/2010 | Phoenix Business Journal | Angela Gonzales
While Arizona's bioscience industry continues its rapid growth in high-paying jobs and firms, a national consultant warns that 2010 may not look so rosy if state budget cuts impact Science Foundation Arizona and state universities' research efforts.
Bioscience makes progress in bad economy
01/12/2010 | East Valley Tribune | Ed Taylor
Heart-monitor company to open Phoenix office
01/12/2010 | Arizona Republic | Ken Alltucker
A Pennsylvania company that makes wireless heart monitors has established a new office in Phoenix. Conshohocken, Pa.-based CardioNet said the new Phoenix office, located at 2750 S. 18th Place, will initially employ 20 with plans to grow up to 50 positions based on the company's growth.
Better than a Band-Aid
01/10/2010 | Arizona Daily Sun | Joe Ferguson
A new company at the Flagstaff business incubator is currently testing a biopolymer that could replace stitches and the use of gauze when treating a deep cut or similar wound. The material, known as Elastatropin, might help wounds heal faster and reduce the amount of scarring, said Protein Genomics CEO Burt Ensley.
